Loading...
PharmaCyte Biotech, Inc.
PMCB•NASDAQ
Healthcare
Biotechnology
$0.95
$0.005(0.53%)
PharmaCyte Biotech, Inc. (PMCB) Financial Performance & Income Statement Overview
Review PharmaCyte Biotech, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-1.00%
↓ 1.00%
Net Income Growth
107.73%
↑ 107.73%
Operating Cash Flow Growth
43.29%
↑ 43.29%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
45.96%
↑ 45.96%
ROIC
-10.56%
↓ 10.56%
PharmaCyte Biotech, Inc. (PMCB) Income Statement & Financial Overview
Review PharmaCyte Biotech, Inc.'s (PMCB) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $97470.00 | $96016.00 | $94183.00 | $126732.00 |
| SG&A Expenses | $117572.00 | $783387.00 | $1.07M | $1.74M |
| Operating Expenses | $1.11M | $1.27M | $1.17M | $1.87M |
| Total Costs & Expenses | $1.11M | $1.27M | $1.17M | $1.87M |
| Interest Income | $382562.00 | $547432.00 | $747098.00 | $881662.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $1.23M | $1869.00 |
| EBITDA | -$1.11M | -$1.27M | $1.35M | -$1.87M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$1.11M | -$1.27M | -$1.17M | -$1.87M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$363500.00 | $24.69M | $4.51M | $1.25M |
| Income Before Tax | -$1.47M | $23.42M | $1.35M | -$619537.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $1.77M | -$1869.00 |
| Net Income | -$1.47M | $23.42M | $1.35M | -$619537.00 |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.39 | $1.90 | $0.17 | -$0.07 |
| Diluted EPS | -$0.39 | $1.90 | $0.17 | -$0.07 |
| Weighted Avg Shares Outstanding | $7.64M | $7.87M | $8.04M | $8.61M |
| Weighted Avg Shares Outstanding (Diluted) | $7.64M | $7.87M | $8.04M | $8.61M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan